PANAGORA ASSET MANAGEMENT INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 129 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,095,000
+42.6%
849,041
+40.4%
0.01%
+50.0%
Q4 2021$768,000
-40.0%
604,941
+3.0%
0.00%
-42.9%
Q3 2021$1,280,000
-42.8%
587,293
-1.6%
0.01%
-41.7%
Q2 2021$2,238,000
+249.7%
596,913
+203.9%
0.01%
+200.0%
Q1 2021$640,000
+1042.9%
196,438
+1102.2%
0.00%
Q4 2020$56,000
-5.1%
16,340
+12.1%
0.00%
Q3 2020$59,000
+20.4%
14,5760.0%0.00%
Q2 2020$49,000
-69.9%
14,576
-79.3%
0.00%
-100.0%
Q1 2020$163,000
-84.3%
70,259
-75.4%
0.00%
-80.0%
Q4 2019$1,039,000
-74.9%
285,541
-42.8%
0.01%
-73.7%
Q3 2019$4,142,000
-16.5%
499,286
-13.3%
0.02%
-13.6%
Q2 2019$4,958,000
-13.5%
575,866
+7.3%
0.02%
-12.0%
Q1 2019$5,735,000
+51.2%
536,518
+23.8%
0.02%
+38.9%
Q4 2018$3,792,000
-67.1%
433,366
-36.9%
0.02%
-58.1%
Q3 2018$11,536,000
-10.2%
686,655
+12.0%
0.04%
-15.7%
Q2 2018$12,849,000
+33.3%
613,037
+2.3%
0.05%
+34.2%
Q1 2018$9,641,000
-16.3%
599,175
-1.5%
0.04%
-11.6%
Q4 2017$11,523,000
+20.1%
608,075
-10.8%
0.04%
+13.2%
Q3 2017$9,592,000
+66.8%
681,736
-11.7%
0.04%
+65.2%
Q2 2017$5,751,000
-9.4%
771,973
-21.0%
0.02%
-11.5%
Q1 2017$6,349,000
+71.2%
976,767
+16.7%
0.03%
+52.9%
Q4 2016$3,708,000
-2.0%
837,126
+3.4%
0.02%
-5.6%
Q3 2016$3,782,000
-40.2%
809,849
-15.8%
0.02%
-41.9%
Q2 2016$6,321,000
-10.6%
962,167
-13.5%
0.03%
-11.4%
Q1 2016$7,071,000
+34.6%
1,111,804
+27.6%
0.04%
+34.6%
Q4 2015$5,255,000
+17.7%
871,474
+16.7%
0.03%
+8.3%
Q3 2015$4,464,000
-2.8%
746,495
+11.2%
0.02%
+4.3%
Q2 2015$4,591,000
+13.1%
671,285
+0.3%
0.02%
+9.5%
Q1 2015$4,061,000
+63.9%
668,971
+87.1%
0.02%
+61.5%
Q4 2014$2,477,000
-11.6%
357,452
+3.8%
0.01%
-7.1%
Q3 2014$2,802,000
-2.1%
344,243
-2.2%
0.01%0.0%
Q2 2014$2,863,000
+83.4%
352,151
+76.9%
0.01%
+100.0%
Q1 2014$1,561,000
+44.7%
199,089
+63.3%
0.01%
+40.0%
Q4 2013$1,079,000
+70.7%
121,913
+61.8%
0.01%
+66.7%
Q3 2013$632,000
-1.6%
75,352
-12.4%
0.00%0.0%
Q2 2013$642,00086,0360.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders